CPRC
JNJ icon

Consolidated Portfolio Review Corp’s Johnson & Johnson JNJ Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,979
Closed -$3.51M – 232
2025
Q3 		$3.51M Buy
18,979
+1,535
+9% +$263K 0.44% 56
2025
Q2 		$2.66M Sell
17,444
-20
-0.1% -$3.07K 0.37% 66
2025
Q1 		$2.9M Buy
17,464
+912
+6% +$143K 0.46% 55
2024
Q4 		$2.39M Buy
16,552
+12,856
+348% +$1.99M 0.38% 70
2024
Q3 		$599K Sell
3,696
-20
-0.5% -$3.19K 0.13% 172
2024
Q2 		$543K Buy
3,716
+673
+22% +$100K 0.13% 175
2024
Q1 		$481K Sell
3,043
-720
-19% -$115K 0.13% 166
2023
Q4 		$590K Sell
3,763
-502
-12% -$77K 0.13% 160
2023
Q3 		$664K Buy
4,265
+7
+0.2% +$1.16K 0.16% 147
2023
Q2 		$705K Buy
4,258
+75
+2% +$12.1K 0.17% 137
2023
Q1 		$648K Buy
+4,183
New +$675K 0.18% 139

Other funds holding JNJ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Consolidated Portfolio Review Corp's JNJ Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Johnson & Johnson (JNJ) in Q4 2025, closing a stake of 18,979 shares — an estimated $3.51M sold.

Consolidated Portfolio Review Corp first reported a position in JNJ in Q1 2023 and held it in 11 quarters. The position peaked at $3.51M in Q3 2025. 4,521 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining Johnson & Johnson position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 18,979 Johnson & Johnson shares in Q4 2025, an estimated $3.51M.
  • Consolidated Portfolio Review Corp first reported a position in Johnson & Johnson in Q1 2023 and held it in 11 quarters.
  • Consolidated Portfolio Review Corp's Johnson & Johnson position peaked at $3.51M in Q3 2025.
  • 4,521 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.